150
Participants
Start Date
August 9, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
August 31, 2026
Tecovirimat Oral Capsule
600 mg, twice daily, 14 days.
Placebo
3 capsules, twice daily, 14 days.
NOT_YET_RECRUITING
Cliniques Universitaires St. Luc, Brussels
RECRUITING
Institute of Tropical Medicine, Antwerp
NOT_YET_RECRUITING
Hospital Clinico San Carlos, Madrid
NOT_YET_RECRUITING
Hospital Universitario La Paz, Madrid
NOT_YET_RECRUITING
Hospital Universitario Virgen Macarena, Seville
NOT_YET_RECRUITING
Universitätsklinikum Bonn, Bonn
NOT_YET_RECRUITING
APHP St. Louis, Paris
NOT_YET_RECRUITING
Hospital Luigi Sacco, Milan
NOT_YET_RECRUITING
Azienda Ospedaliera Universitaria Integrata Verona - AOUI Verona, Verona
NOT_YET_RECRUITING
Amsterdam UMC - AMC, Amsterdam
NOT_YET_RECRUITING
Oslo Unversity Hospital, Oslo
NOT_YET_RECRUITING
Hospital de Santo António dos Capuchos, Lisbon
Collaborators (1)
European Clinical Research Alliance for Infectious Diseases (ECRAID)
OTHER
Erasmus Medical Center
OTHER
Hospital Universitario La Paz
OTHER
ANRS, Emerging Infectious Diseases
OTHER_GOV
Universiteit Antwerpen
OTHER
Miquel Ekkelenkamp
OTHER